User profiles for "author:F Brennan"

Fiona Brennan

Environment, Soils and Land-Use Department, Teagasc, Johnstown Castle
Verified email at teagasc.ie
Cited by 1920

Role of cytokines in rheumatoid arthritis

M Feldmann, FM Brennan… - Annual review of …, 1996 - annualreviews.org
▪ Abstract Analysis of cytokine mRNA and protein in rheumatoid arthritis tissue revealed that
many proinflammatory cytokines such as TNFα, IL-1, IL-6, GM-CSF, and chemokines such …

[HTML][HTML] Evidence that cytokines play a role in rheumatoid arthritis

FM Brennan, IB McInnes - The Journal of clinical …, 2008 - Am Soc Clin Investig
A large number of cytokines are active in the joints of patients with rheumatoid arthritis (RA).
It is now clear that these cytokines play a fundamental role in the processes that cause …

Pain management: a fundamental human right

F Brennan, DB Carr, M Cousins - Anesthesia & Analgesia, 2007 - journals.lww.com
This article surveys worldwide medical, ethical, and legal trends and initiatives related to the
concept of pain management as a human right. This concept recently gained momentum …

Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

FM Brennan, A Jackson, D Chantry, R Maini… - The Lancet, 1989 - Elsevier
The effect of tumour necrosis factor (TNFα) antibodies on synovial cell interleukin-1 (IL-1)
production was investigated in 7 patients with rheumatoid arthritis and in 7 with …

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

MJ Elliott, RN Maini, M Feldmann… - Arthritis & …, 1993 - Wiley Online Library
Objective. To evaluate the safety and efficacy of a chimeric monoclonal antibody to tumor
necrosis factor α (TNFα) in the treatment of patients with rheumatoid arthritis (RA). Methods …

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

…, N Sofat, M Kashiwagi, G Orend, F Brennan… - Nature medicine, 2009 - nature.com
Although there have been major advances in the treatment of rheumatoid arthritis with the
advent of biological agents, the mechanisms that drive cytokine production and sustain …

[HTML][HTML] Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care

…, A Levin, AH Moss, V Jha, EA Brown, F Brennan… - Kidney international, 2015 - Elsevier
Patients with advanced chronic kidney disease (CKD) have a high burden of physical and
psychosocial symptoms, poor outcomes, and high costs of care. Current paradigms of care …

Immunoregulatory role of interleukin 10 in rheumatoid arthritis.

PD Katsikis, CQ Chu, FM Brennan, RN Maini… - The Journal of …, 1994 - rupress.org
The presence and the role of interleukin 10 (IL-10), a potent cytokine synthesis inhibitory
factor and antiinflammatory cytokine, were investigated in rheumatoid arthritis (RA). The …

TNFα—a pivotal role in rheumatoid arthritis?

FM BRENNAN, RN Maini, M Feldmann - Rheumatology, 1992 - academic.oup.com
This review seeks to describe data which support the concept that TNFα has a pivotal role in
the pathogenesis of RA. There is now compelling evidence from in vitro studies and in …

Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor‐α

C Haworth, FM Brennan, D Chantry… - European journal of …, 1991 - Wiley Online Library
Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), in addition to being a growth
factor for granulocytes and macrophages, is an activator of cells of the monocyte …